Abstract

Get full access to this article
View all access options for this article.
References
1.
Soules
M
Sherman
S
Parrott
E
Executive summary: stages of reproductive aging workshop, Park City, Utah, July 2001 . Menopause
2001 ;8 :402 –7 .
2.
Richardson
SJ
Nelson
JF
. Follicular depletion during the menopausal transition . Ann NY Acad Sc
1990 ;592 :13 –20 .
3.
Burger
HG
Dudley
EC
Hopper
JL
The endocrinology of the menopausal transition . J Clin Endocrinol Metab
1995 ;80 :3537 –45 .
4.ACOG Committee Opinion No. 452 . Primary and preventive care: periodic assessments . Obstet Gynecol
2009 ;114 (6 ):1444 –51 .
5.
Barbieri
RL
Lobo
RA
Walsh
BW
Improving quality of life during menopause. APGO Educational Series on Women's Health Issues . Crofton (MD) : Association of Professors of Gynecology and Obstetrics ; 2002 . Texte publié sur le site: www.apgo.org/foundation/index.cfm?cat=educational%20series (consulté le 10 septembre 2010).
6.
Shifren
JL
Schiff
I
. Role of hormone therapy in the management of menopause . Obstet Gynecol
2010 ;115 (4 ):839 –55 .
7.
Lukes
A
. Evolving issues in the clinical and managed care settings on the management of menopause following the WHI . J Manag Care Pharm
2008 ;14 (3 suppl ):7 –13 .
8.Royal College of Obstetricians and Gynaecologists . Alternatives to HRT for the management of symptoms of the menopause . Scientific Advisory Committee Opinion Paper 6. May 2006 . Texte publié sur le site:www.rcog.org.uk/womens-health/clinical-guidance/alternatives-hrt-management-symptoms-menopause (consulté le 7 septembre 2010).
9.
Feero
WG
Guttmacher
AE
Collins
FS
. Genomic medicine — an updated primer . N Engl J Med
2010 ;362 (21 ):2001 –11 .
